Skip to main content
Equibles

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in WHWK — Whitehawk Therapeutics, Inc.

CIK 884546 SAN FRANCISCO, CA
Back to WHWK Full portfolio

Position in WHWK

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$361,050
+$274,295 QoQ
Shares Held
78,832
+112.6% QoQ
Ownership
0.138%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 78 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in WHWK Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. WHWK ranks #270 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,041,282 $1,013,966,007
2 REGN
Regeneron Pharmaceuticals, Inc.
 846,306 $527,705,642
3 RVMD
Revolution Medicines, Inc.
 1,917,025 $359,020,441
4 MRNA
Moderna, Inc.
 4,838,884 $338,867,045
5 ALNY
Alnylam Pharmaceuticals, Inc.
 755,377 $227,391,137
6 INCY
Incyte Corp
 1,692,439 $191,854,884
7 RPRX
Royalty Pharma plc
 3,083,528 $172,893,414
8 CYTK
Cytokinetics Inc
 1,565,781 $133,388,883

All Filings in WHWK

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $361,050 78,832
2024-03-31 $86,755 37,075
2023-12-31 $91,645 45,369
2023-09-30 $219,585 45,369
2023-06-30 $310,323 45,369
2023-03-31 $298,425 41,219
2022-12-31 $528,839 41,219
2022-09-30 $512,254 36,253
2022-06-30 $490,952 39,850